[Focal segmental glomerulosclerosis (FSGS). Molecular defects and clinical relevance].
Schiffer
M
M
Abteilung für Nieren- und Hochdruckkrankheiten, Medizinische Hochschule Hannover. schiffer.mario@mh-hannover.de
Haller
H
H
D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D003598:Cytoskeletal Proteins / Q000235:genetics / Q000502:physiology; D004195:Disease Models, Animal; D005923:Glomerulosclerosis, Focal Segmental / Q000175:diagnosis / Q000235:genetics / Q000473:pathology / Q000628:therapy; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins / Q000235:genetics; D009154:Mutation; D050199:Podocytes / Q000473:pathology; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000502:physiology
D048868:Adaptor Proteins, Signal Transducing; C114545:CD2-associated protein; D003598:Cytoskeletal Proteins; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; C407223:NPHS2 protein; D016212:Transforming Growth Factor beta